Evidence map›Paper›PMID 42337226›Full record

ArticleBlood cancer journal2026

Long-term follow-up of the transplant-eligible cohort of the EMN12/HOVON-129 study for primary plasma cell leukemia patients.

Niels W C J van de Donk, Fredrik Schjesvold, Bronno van der Holt, Monique C Minnema, Ka Lung Wu, Annemiek Broijl, Wilfried W H Roeloffzen, Alain Gadisseur, Giuseppe Pietrantuono, Ludek Pour and 18 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood cancer journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Niels W C J van de DonkDepartment of Hematology and Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands. n.vandedonk@amsterdamumc.nl.ORCID http://orcid.org/0000-0002-7445-2603
Fredrik SchjesvoldDepartment of Hematology, Oslo Myeloma Center, Oslo University Hospital and KG Jebsen Center for B Cell Malignancies, University of Oslo, Oslo, Norway.ORCID http://orcid.org/0000-0003-1096-0569
Bronno van der HoltHOVON Foundation, Rotterdam, The Netherlands.ORCID http://orcid.org/0000-0001-6414-2671
Monique C MinnemaDepartment of Hematology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0002-3139-8379
Ka Lung WuDepartment of Hematology, ZAS Cadix, Antwerp, Belgium.
Annemiek BroijlDepartment of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Wilfried W H RoeloffzenDepartment of Hematology, University Medical Center Groningen, University Groningen, Groningen, The Netherlands.ORCID http://orcid.org/0000-0003-3976-8001
Alain GadisseurDepartment of Haematology, Antwerp University Hospital, Edegem, Belgium.
Giuseppe PietrantuonoUnit of Hematology, Centro di Riferimento Oncologico della Basilicata (IRCCS-CROB), Rionero in Vulture, PZ, Italy.
Ludek PourDepartment of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czechia.
Vincent H J van der VeldenDepartment of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.ORCID http://orcid.org/0000-0001-9457-3763
Thomas LundHematological Division, Vejle Hospital, Vejle, Denmark.ORCID http://orcid.org/0000-0003-3509-3780
Massimo OffidaniAOU delle Marche, Ancona, Italy.ORCID http://orcid.org/0000-0003-2749-7347
Sara BringhenDivision of Hematology, Azienda Sanitaria Ospedaliera S. Croce e Carle, Cuneo, Italy.ORCID http://orcid.org/0000-0003-4539-6363
Luisa GiacconeDepartment of Oncology and Hematology, SSD Stem Cell Transplant Center, A.O.U. Città della Salute e della Scienza di Torino, Torino, Italy.
Wida RazawyHOVON Foundation, Rotterdam, The Netherlands.
Paola TacchettiIRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna, Italy.
Katia MancusoIRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna, Italy.
Trine SilkjaerAarhus University Hospital, Aarhus, Denmark.
Jo CaersDepartment of Hematology, CHU Liege, Liege, Belgium.ORCID http://orcid.org/0000-0002-3175-1195
Sonja ZweegmanDepartment of Hematology and Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Roman HájekDepartment of Hematooncology, University Hospital Ostrava, Ostrava, Czechia.ORCID http://orcid.org/0000-0001-6955-6267
Reuben BenjaminKing's College Hospital, London, UK.
Annette Juul VangstedDepartment of Hematology, Rigshospitalet, Copenhagen University, Copenhagen, Denmark.ORCID http://orcid.org/0000-0002-2131-731X
Mario BoccadoroEuropean Myeloma Network (EMN), Turin, Italy.
Francesca GayDivision of Hematology, Department of Molecular Biotechnology and Health Sciences, AOU Città della Salute e della Scienza di Torino, University of Torino, Torino, Italy.ORCID http://orcid.org/0000-0002-8619-412X
Pieter SonneveldDepartment of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.ORCID http://orcid.org/0000-0002-0808-2237
Pellegrino MustoDepartment of Precision and Regenerative Medicine and Ionian Area, AOU Consorziale Policlinico, "Aldo Moro" University School of Medicine, and Hematology and Stem Cell Transplantation Unit, Bari, Italy.ORCID http://orcid.org/0000-0003-3277-6594

Funding

Amgen Foundation (Amgen Foundation, Inc.) 2005-002Bristol-Myers Squibb (Bristol-Myers Squibb Company) 2005-001KWF Kankerbestrijding (Dutch Cancer Society) 2005-003
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42337226
PMCPMC13291338

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.